Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Cantargia AB: Cantargia Raises kSEK 250 Through Exercise of Warrants

Cantargia AB
Posted on: 22 Aug 16

Cantargia AB (“Cantargia”) has today announced that the company’s former CEO, Agneta Svedberg, has exercised 1,250 warrants of series 2011/2016. The exercise of the warrants will raise SEK 250,212.50 for Cantargia.

Agneta Svedberg has exercised her full holding of 1,250 warrants, which gave her the right to subscribe for 37 shares per warrant at a price of SEK 5.41 per share. The exercise of the warrants will result in a dilution of around 0.3 per cent for existing shareholders. Upon registration with the Swedish Companies Registration Office, the total number of outstanding shares of Cantargia will be 17,679,384. The share capital will be SEK 1,414,350.72.

This constitutes information that Cantargia is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person at 8:30 (CEST) on August 22, 2016.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160821005046/en/

Business Wire
www.businesswire.com

Last updated on: 22/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.